- Home
- INBX vs PROF Comparison
INBX vs PROF Comparison
Compare INBX & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- PROF
- Stock Information
- Founded
- INBX 2010
- PROF N/A
- Country
- INBX United States
- PROF Canada
- Employees
- INBX N/A
- PROF N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- PROF Medical/Dental Instruments
- Sector
- INBX Health Care
- PROF Health Care
- Exchange
- INBX Nasdaq
- PROF Nasdaq
- Market Cap
- INBX 178.5M
- PROF 164.4M
- IPO Year
- INBX 2020
- PROF N/A
- Fundamental
- Price
- INBX $11.28
- PROF $4.27
- Analyst Decision
- INBX Hold
- PROF Strong Buy
- Analyst Count
- INBX 1
- PROF 2
- Target Price
- INBX N/A
- PROF $11.50
- AVG Volume (30 Days)
- INBX 94.2K
- PROF 79.0K
- Earning Date
- INBX 05-20-2025
- PROF 05-08-2025
- Dividend Yield
- INBX 7.45%
- PROF N/A
- EPS Growth
- INBX N/A
- PROF N/A
- EPS
- INBX 112.62
- PROF N/A
- Revenue
- INBX $200,000.00
- PROF $11,862,000.00
- Revenue This Year
- INBX N/A
- PROF $71.17
- Revenue Next Year
- INBX N/A
- PROF $134.25
- P/E Ratio
- INBX $0.10
- PROF N/A
- Revenue Growth
- INBX N/A
- PROF 75.01
- 52 Week Low
- INBX $10.80
- PROF $3.90
- 52 Week High
- INBX $18.95
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- INBX 41.19
- PROF 34.68
- Support Level
- INBX $10.90
- PROF $4.62
- Resistance Level
- INBX $11.98
- PROF $5.62
- Average True Range (ATR)
- INBX 0.85
- PROF 0.42
- MACD
- INBX -0.02
- PROF -0.01
- Stochastic Oscillator
- INBX 19.75
- PROF 8.45
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.